BrainStorm Cell Therapeutics’ (BCLI) CEO Chaim Lebovits on Q3 2017 Results – Earnings Call Transcript – Seeking Alpha
Weekly Register |
BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q3 2017 Results – Earnings Call Transcript
Seeking Alpha The first patients have been enrolled in the study and we're also really pleased about the support that we've received from CIRM, California stem cell agency to provide funding for this important project. We are working with the top leading ALS centers … BrainStorm Announces Third Quarter 2017 Financial Results BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS Brainstorm Cell Therapeutics (NASDAQ:BCLI) Getting Somewhat Favorable Press Coverage, Report Shows |
